Anúncio
Anúncio
ORIC
Oric Pharmaceuticals, Inc. Common Stock
9.14
USDPatrocinado
+0.69
+8.20%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
9.21
+0.07
+0.72%
Relatórios de Lucros ORIC
Rácio de surpresa positiva
ORIC separação 12 de 23 últimas estimativas.
52%
Próximo Relatório
Data do Próximo Relatório
16 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.36
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+9.09%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-29.41%
Oric Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 13 de nov. de 2025, ORIC reported earnings of -0.33 USD per share (EPS) for Q3 25, beating the estimate of -0.41 USD, resulting in a 20.14% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.49% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of -0.36 USD, with revenue projected to reach -- USD, implying an aumentar of 9.09% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Oric Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Oric Pharmaceuticals, Inc. Common Stock reported EPS of -$0.33, beating estimates by 20.14%, and revenue of $0.00, 0% as expectations.
How did the market react to Oric Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 0.49%, changed from $12.19 before the earnings release to $12.25 the day after.
When is Oric Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 16 de fev. de 2026.
What are the forecasts for Oric Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 17
analistas, Oric Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.36 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio